|
AU2017289071A1
|
|
Stimulating platelet generation by activating mitochondrial biogenesis
|
|
US2017246470A1
|
|
Systems and methods for enhancing platelet biogenesis and extending platelet lifespan with low level light
|
|
WO2017124028A1
|
|
Systems and methods for removing exogenous particles from the skin of a patient
|
|
AU2016324160A1
|
|
Localized delivery of anti-fugetactic agent for treatment of cancer
|
|
AU2016324297A1
|
|
Compositions having anti-fugetactic properties for treatment of cancer
|
|
CN108348545A
|
|
With the T cell of modification and application thereof for resisting to become except characteristic
|
|
WO2017049237A1
|
|
Personalized approach to dosage of anti-fugetactic agent for treatment of cancer
|
|
AU2012216443A1
|
|
Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hy-drogel formulations
|
